Order Article Reprints

Hartlage-Rübsamen M, Bluhm A, Piechotta A, Linnert M, Rahfeld J-U, Demuth H-U, Lues I, Kuhn P-H, Lichtenthaler SF, Roßner S, et al. Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation. Molecules. 2018; 23(4):924. https://doi.org/10.3390/molecules23040924

Hartlage-Rübsamen, Maike, Alexandra Bluhm, Anke Piechotta, Miriam Linnert, Jens-Ulrich Rahfeld, Hans-Ulrich Demuth, Inge Lues, Peer-Hendrik Kuhn, Stefan F. Lichtenthaler, Steffen Roßner, and et al. 2018. "Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation" Molecules 23, no. 4: 924. https://doi.org/10.3390/molecules23040924

Hartlage-Rübsamen, M., Bluhm, A., Piechotta, A., Linnert, M., Rahfeld, J.-U., Demuth, H.-U., Lues, I., Kuhn, P.-H., Lichtenthaler, S. F., Roßner, S., & Höfling, C. (2018). Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation. Molecules, 23(4), 924. https://doi.org/10.3390/molecules23040924